Tenaya Net Receivables vs Non Current Liabilities Total Analysis

TNYA Stock

USD 3.58 0.20 5.29%

Tenaya Therapeutics financial indicator trend analysis is much more than just breaking down Tenaya Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tenaya Therapeutics is a good investment. Please check the relationship between Tenaya Therapeutics Net Receivables and its Non Current Liabilities Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tenaya Therapeutics Net Receivables account and Non Current Liabilities Total. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Tenaya Therapeutics' Net Receivables and Non Current Liabilities Total is 0.45. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Tenaya Therapeutics, assuming nothing else is changed. The correlation between historical values of Tenaya Therapeutics' Net Receivables and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Tenaya Therapeutics are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Net Receivables i.e., Tenaya Therapeutics' Net Receivables and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.45

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Receivables

Non Current Liabilities Total

Most indicators from Tenaya Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tenaya Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 119.9 M, whereas Selling General Administrative is forecasted to decline to about 20.9 M.

	2021	2022	2023	2024 (projected)
Interest Income	108K	2.0M	6.6M	7.0M
Net Interest Income	108K	2.0M	6.6M	7.0M

Interest Income Net Interest Income

Tenaya Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		0.86	0.92	0.93	-0.93	0.88	0.94	-0.42	-0.73	0.96	0.62	0.93	0.87	0.71	0.99	0.36	0.9	-0.43	0.93	0.88	0.25	0.93	0.88	0.99	0.82	0.98
Other Current Liab	0.86		0.97	0.89	-0.97	0.96	0.96	-0.18	-0.92	0.88	0.41	0.92	0.99	0.4	0.8	0.77	0.78	-0.63	0.9	0.98	-0.05	0.89	0.97	0.81	0.57	0.78
Total Current Liabilities	0.92	0.97		0.96	-0.98	0.97	1.0	-0.21	-0.88	0.96	0.44	0.98	0.99	0.59	0.87	0.63	0.83	-0.67	0.98	1.0	0.1	0.96	0.99	0.87	0.72	0.84
Total Stockholder Equity	0.93	0.89	0.96		-0.93	0.94	0.96	-0.1	-0.74	0.99	0.32	0.95	0.92	0.72	0.89	0.43	0.93	-0.72	0.97	0.94	0.06	1.0	0.91	0.89	0.86	0.87
Other Liab	-0.93	-0.97	-0.98	-0.93		-0.98	-0.98	0.25	0.91	-0.94	-0.51	-0.96	-0.97	-0.5	-0.89	-0.63	-0.83	0.61	-0.95	-0.97	-0.05	-0.93	-0.97	-0.9	-0.65	-0.87
Net Tangible Assets	0.88	0.96	0.97	0.94	-0.98		0.96	-0.07	-0.91	0.93	0.35	0.93	0.96	0.45	0.83	0.65	0.84	-0.75	0.93	0.96	-0.1	0.94	0.94	0.83	0.63	0.8
Property Plant And Equipment Net	0.94	0.96	1.0	0.96	-0.98	0.96		-0.28	-0.86	0.96	0.51	0.99	0.98	0.62	0.9	0.58	0.84	-0.62	0.98	0.99	0.16	0.96	0.98	0.9	0.74	0.87
Net Debt	-0.42	-0.18	-0.21	-0.1	0.25	-0.07	-0.28		0.21	-0.2	-0.94	-0.32	-0.19	-0.31	-0.45	-0.02	-0.04	-0.54	-0.27	-0.18	-0.82	-0.1	-0.28	-0.44	-0.18	-0.46
Retained Earnings	-0.73	-0.92	-0.88	-0.74	0.91	-0.91	-0.86	0.21		-0.73	-0.48	-0.85	-0.91	-0.16	-0.66	-0.83	-0.56	0.6	-0.81	-0.89	0.03	-0.74	-0.91	-0.67	-0.31	-0.63
Accounts Payable	0.96	0.88	0.96	0.99	-0.94	0.93	0.96	-0.2	-0.73		0.42	0.95	0.91	0.75	0.94	0.38	0.94	-0.63	0.97	0.93	0.13	0.99	0.9	0.94	0.87	0.92
Cash	0.62	0.41	0.44	0.32	-0.51	0.35	0.51	-0.94	-0.48	0.42		0.54	0.41	0.34	0.64	0.18	0.25	0.29	0.49	0.41	0.71	0.32	0.5	0.63	0.28	0.64
Non Current Assets Total	0.93	0.92	0.98	0.95	-0.96	0.93	0.99	-0.32	-0.85	0.95	0.54		0.96	0.66	0.88	0.54	0.79	-0.61	1.0	0.97	0.26	0.95	0.98	0.87	0.74	0.85
Non Currrent Assets Other	0.87	0.99	0.99	0.92	-0.97	0.96	0.98	-0.19	-0.91	0.91	0.41	0.96		0.49	0.81	0.73	0.77	-0.67	0.95	1.0	0.04	0.92	0.99	0.81	0.63	0.78
Other Assets	0.71	0.4	0.59	0.72	-0.5	0.45	0.62	-0.31	-0.16	0.75	0.34	0.66	0.49		0.73	-0.21	0.7	-0.29	0.7	0.54	0.52	0.72	0.52	0.71	0.96	0.71
Cash And Short Term Investments	0.99	0.8	0.87	0.89	-0.89	0.83	0.9	-0.45	-0.66	0.94	0.64	0.88	0.81	0.73		0.27	0.9	-0.35	0.88	0.83	0.27	0.89	0.82	1.0	0.83	1.0
Common Stock Shares Outstanding	0.36	0.77	0.63	0.43	-0.63	0.65	0.58	-0.02	-0.83	0.38	0.18	0.54	0.73	-0.21	0.27		0.24	-0.46	0.48	0.68	-0.26	0.43	0.7	0.29	-0.05	0.24
Short Term Investments	0.9	0.78	0.83	0.93	-0.83	0.84	0.84	-0.04	-0.56	0.94	0.25	0.79	0.77	0.7	0.9	0.24		-0.59	0.82	0.8	-0.09	0.93	0.74	0.91	0.87	0.9
Non Current Liabilities Total	-0.43	-0.63	-0.67	-0.72	0.61	-0.75	-0.62	-0.54	0.6	-0.63	0.29	-0.61	-0.67	-0.29	-0.35	-0.46	-0.59		-0.65	-0.68	0.4	-0.72	-0.63	-0.35	-0.45	-0.31
Other Current Assets	0.93	0.9	0.98	0.97	-0.95	0.93	0.98	-0.27	-0.81	0.97	0.49	1.0	0.95	0.7	0.88	0.48	0.82	-0.65		0.96	0.24	0.97	0.96	0.88	0.79	0.85
Other Stockholder Equity	0.88	0.98	1.0	0.94	-0.97	0.96	0.99	-0.18	-0.89	0.93	0.41	0.97	1.0	0.54	0.83	0.68	0.8	-0.68	0.96		0.07	0.94	0.99	0.83	0.67	0.79
Total Liab	0.25	-0.05	0.1	0.06	-0.05	-0.1	0.16	-0.82	0.03	0.13	0.71	0.26	0.04	0.52	0.27	-0.26	-0.09	0.4	0.24	0.07		0.06	0.16	0.23	0.29	0.25
Net Invested Capital	0.93	0.89	0.96	1.0	-0.93	0.94	0.96	-0.1	-0.74	0.99	0.32	0.95	0.92	0.72	0.89	0.43	0.93	-0.72	0.97	0.94	0.06		0.91	0.89	0.86	0.87
Property Plant And Equipment Gross	0.88	0.97	0.99	0.91	-0.97	0.94	0.98	-0.28	-0.91	0.9	0.5	0.98	0.99	0.52	0.82	0.7	0.74	-0.63	0.96	0.99	0.16	0.91		0.82	0.63	0.78
Total Current Assets	0.99	0.81	0.87	0.89	-0.9	0.83	0.9	-0.44	-0.67	0.94	0.63	0.87	0.81	0.71	1.0	0.29	0.91	-0.35	0.88	0.83	0.23	0.89	0.82		0.82	1.0
Non Current Liabilities Other	0.82	0.57	0.72	0.86	-0.65	0.63	0.74	-0.18	-0.31	0.87	0.28	0.74	0.63	0.96	0.83	-0.05	0.87	-0.45	0.79	0.67	0.29	0.86	0.63	0.82		0.82
Net Working Capital	0.98	0.78	0.84	0.87	-0.87	0.8	0.87	-0.46	-0.63	0.92	0.64	0.85	0.78	0.71	1.0	0.24	0.9	-0.31	0.85	0.79	0.25	0.87	0.78	1.0	0.82

Click cells to compare fundamentals

Tenaya Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Tenaya Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenaya Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenaya Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenaya Therapeutics Stock:

How To Invest In Tenaya

Details

Is Tenaya Stock a good investment?

Details

What is Tenaya Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.44)

Return On Assets

(0.46)

Return On Equity

(0.84)

The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tenaya Net Receivables vs Non Current Liabilities Total Analysis

Net Receivables vs Non Current Liabilities Total

Net Receivables vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Net Receivables

Non Current Liabilities Total

Tenaya Therapeutics fundamental ratios Correlations

Tenaya Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Total Current Liabilities
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Other Current Assets	+ 1.0	Non Current Assets Total
Other Stockholder Equity	+ 1.0	Non Currrent Assets Other
Total Current Assets	+ 1.0	Cash And Short Term Investments

Property Plant And Equipment Net	- 0.98	Other Liab
Net Tangible Assets	- 0.98	Other Liab
Other Liab	- 0.98	Total Current Liabilities
Property Plant And Equipment Gross	- 0.97	Other Liab
Other Stockholder Equity	- 0.97	Other Liab
Non Currrent Assets Other	- 0.97	Other Liab